Biomerica (BMRA) EBIAT (2016 - 2025)
Biomerica's EBIAT history spans 16 years, with the latest figure at -$1.3 million for Q4 2025.
- For Q4 2025, EBIAT fell 38.95% year-over-year to -$1.3 million; the TTM value through Nov 2025 reached -$4.0 million, up 28.19%, while the annual FY2025 figure was -$5.0 million, 16.81% up from the prior year.
- EBIAT for Q4 2025 was -$1.3 million at Biomerica, down from $2000.0 in the prior quarter.
- Across five years, EBIAT topped out at $2000.0 in Q3 2025 and bottomed at -$2.1 million in Q1 2021.
- The 5-year median for EBIAT is -$1.5 million (2021), against an average of -$1.4 million.
- The largest annual shift saw EBIAT tumbled 1483.84% in 2023 before it surged 100.15% in 2025.
- A 5-year view of EBIAT shows it stood at -$1.1 million in 2021, then tumbled by 44.5% to -$1.6 million in 2022, then increased by 7.32% to -$1.5 million in 2023, then soared by 36.96% to -$950000.0 in 2024, then plummeted by 38.95% to -$1.3 million in 2025.
- Per Business Quant, the three most recent readings for BMRA's EBIAT are -$1.3 million (Q4 2025), $2000.0 (Q3 2025), and -$1.5 million (Q2 2025).